Searched for
LECANEMAB
Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriersA new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...- Alzheimer disease symptoms treatment: Can Alzheimer's be prevented? Doctors, health experts say yes, prescribe ways to check dementiaWhat makes people more at risk of getting Alzheimer's disease and dementia more broadly? Nearly half of all cases are linked to factors suc...
- Here's a long-awaited new FDA-Approved treatment for Alzheimer's - Read moreThis could mark a new era for Alzheimer's treatment as the FDA grants full approval to a promising new drug called 'Lecanemab.' The drug is...
- Japan's Nikkei closes at 2-week high on tech boostJapan's central bank last month widened the trading band for the benchmark 10-year government bonds to 0.5% from 0.25%, sending yields acro...
- New Alzheimer drug 'lecanemab' by Eisai Co and Biogen shows positive results but......, read what study saysThe ‘Eisai’ and ‘Biogen’ drug slowed cognitive decline in study participants, but many experienced brain bleeds, swelling, or other side ef...
- Hope for Alzheimer’s patients as researchers make breakthrough with Lecanemab drug that slows memory declineIt is an outcome of a trial on 1,795 people in early stages of the disease.
- Alzheimer’s game-changing drug may be available for patients from next year, reveals expertOne of the world's leading experts has predicted that patients could receive the revolutionary Alzheimer's treatment as early as next year....
- Roche's Alzheimer's drug fails to meet goal in long awaited trialRoche's Alzheimer's drug candidate could not be shown to markedly slow dementia progression in two drug trials, leaving rivals Biogen and E...
- Lecanemab: All about the Alzheimer's drug that shows promiseClinical trials on 1800 patients with early-stage Alzheimer's has showed that Lecanemab slows the advance of the disease.
- At last, a drug to slow down Alzheimer'sEisai Co, a Tokyo-based pharmaceutical company with a family bent and market capitalisation of $14 billion, crossed the finish line before ...
- Japanese drugmaker Eisai comes up with new drug Lecanemab for treating Alzheimer's disease. See if it is effective?There is a new drug, which can probably help in treating Alzheimer's disease, but the authorities are yet to approve it, even though clinic...
- Japan's Nikkei ends at near 3-month low on global recession fearsInvestors globally are on edge as surging borrowing costs stoke fears of widespread recession, with most of the world's major central banks...
- Japan's Nikkei falls on slowdown worries, energy losses"Investors' focus have shifted to slowdown risks stemming from the ongoing tightening monetary policy," said Ikuo Mitsui, fund manager at A...
- World Alzheimer’s Day: 45 mins of daily exercise, 7-8 hrs of sleep, protein-rich diet can keep disease at bayAir pollution and other environmental factors can also speed up the onset of Azhiemer’s disease.
- Nikkei ends flat as Japan shares stay tepid over corporate earnings uncertaintyNikkei share average was flat at 28,875.23, while the broader Topix slipped 0.10 per cent to 1,947.10.
Load More
